AzTrials
AzTrials

Prevention of Voice Disorders in Professional Voice UsersNCT06960772

Efficacy of Flow Ball Phonation in Professional Voice Users

A study testing Flow Ball Intervention and Straw Phonation Intervention in people with Prevention of Voice Disorders in Professional Voice Users and Treatment of Functional Voice Disorders in Professional Voice Users, run by University Ghent at 1 site in Belgium.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

The aim of this study is to investigate the effects of flow ball phonation on the voice of professional voice users and elite vocal performers, both with and without functional voice disorders. Read more about this study

Who is it for?
Ages 18 to 60 yearsHealthy volunteers can take part
What is being tested?
Flow Ball Intervention and Straw Phonation Intervention
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
144 participants
Where
1 siteBelgium
Study dates
8 May 2025to 30 Sep 2028
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 60 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • All genders
  • All ethnicities
  • 18 - 60 years
  • Diagnosis of a functional voice disorder
  • Professional voice users
  • All genders
Show all 9Show fewer
  • All ethnicities
  • 18 - 60 years
  • Professional voice users

Who cannot join

  • Diagnosis of an organic voice disorder
  • Current participation in voice therapy
  • Previous phonosurgical interventions
  • Pregnancy
  • Smoking
  • Nasal or ear diseases
Show all 15Show fewer
  • Neurological disorders
  • OBJECTIVE 2: PREVENTION
  • Current or previous diagnosis of a voice disorder
  • Current or previous participation in voice therapy
  • Previous phonosurgical interventions
  • Pregnancy
  • Smoking
  • Nasal or ear diseases
  • Neurological disorders

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Belgium1 site, 1 recruiting
  • Ghent University

    Ghent, East-Flanders, 9000

    Casey Dewanckele, +32491547192, casey.dewanckele@ugent.be

    Evelien D'haeseleer

    Recruiting

Other trials in Belgium

About this study

The aim of this study is to investigate the effects of flow ball phonation on the voice of professional voice users and elite vocal performers, both with and without functional voice disorders. Given the substantial vocal demands inherent to this population and their reliance on the voice for occupational purposes, this intervention may represent a valuable approach for the prevention and/or treatment voice disorders.

Read the detailed description

Background. Due to the high vocal demands, professional voice users (e.g. teachers) and elite vocal performers (e.g. singers) are risk populations for developing voice disorders. High-quality voice research in these vulnerable populations is highly needed for effective and efficient treatment and prevention of voice disorders. The flow ball (FB) is a promising innovative voice therapy device to perform semi-occluded vocal tract exercises (SOVTE) with the extra advantage of providing real-time visual feedback of the airflow. Despite this important advantage, strong efficacy studies of an FB intervention program are lacking.

Objective. To investigate the immediate-, short- and long-term effects of an SOVTE intervention with the FB on the phonation of professional voice users with (treatment) and without (prevention) voice disorders and to compare it with the 'treatment as usual' straw phonation (SP) and a sham condition, using a longitudinal randomized sham-controlled trial (RCT).

Methods. Subjects will be randomly assigned into an FB group, an SP group or a control (sham) group. They will receive a short-term intensive voice intervention of 3 weeks, combining both guided therapy/training sessions and independent practice at home. A flexible strobovideolaryngoscopy and a multidimensional voice assessment will be performed by assessors blinded to group allocation and study phase. Assessments will be performed two times before the intervention (pre 1 and pre 2), immediately after the intensive intervention (post 1) and at 3 weeks (follow-up 1) and 3 months (follow-up 2) follow-up. The sham group will use the same FB device but no phonation will be involved.

Being tested
Flow Ball Intervention, Straw Phonation Intervention, Sham Intervention
Keywords
Flow Ball, SOVTE, professional voice users, Straw Phonation

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Flow Ball InterventionBehavioural

    Participants receive an intensive intervention using the Flow Ball device over 3 weeks (a total of 5 hours), consisting of weekly:

    • 1 in-person guided session of 30 minutes
    • 2 guided online sessions of 15 minutes each (via teleconsult)
    • On the remaining 4 days of the week, participants perform independent training at home: 5 minutes, twice daily. This training is recorded using the app 'MyMedicoach'
  • Straw Phonation InterventionBehavioural

    Participants receive an intensive intervention using a straw over 3 weeks (a total of 5 hours), consisting of weekly:

    • 1 in-person guided session of 30 minutes
    • 2 guided online sessions of 15 minutes each (via teleconsult)
    • On the remaining 4 days of the week, participants perform independent training at home: 5 minutes, twice daily. This training is recorded using the app 'MyMedicoach'
  • Sham InterventionBehavioural

    Participants receive an intensive intervention over 3 weeks (a total of 5 hours), consisting of weekly:

    • 1 in-person guided session of 30 minutes
    • 2 guided online sessions of 15 minutes each (via teleconsult)
    • On the remaining 4 days of the week, participants perform independent training at home: 5 minutes, twice daily. This training is recorded using the app 'MyMedicoach' The sham intervention uses breathing exercises through the Flow Ball, no phonation will be involved.
Study groups in NCT06960772
Study groupRoleWhat they receive
Flow BallExperimentalNot described
Receives: Behavioral: Flow Ball Intervention
Straw PhonationExperimentalNot described
Receives: Behavioral: Straw Phonation Intervention
Sham InterventionSham comparatorNot described
Receives: Behavioral: Sham Intervention

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Flexible Strobovideolaryngoscopy

    Laryngeal function determined with the Voice-Vibratory Assessment with Laryngeal Imaging (VALI) rating form (Poburka et al., 2017).

    Measured: baseline (before the intervention) and 3 weeks (immediately after the intervention)

  2. Dysphonia Severity Index (DSI)

    DSI: A higher index indicates a better voice quality. The index ranges from -5 to +5 for severely dysphonic to normal voices. A more negative index indicates a worse voice quality. Values > +5 are possible in subjects with excellent vocal capacities. A DSI = +1.6 is the threshold separating normophonic from dysphonic persons.

    Measured: baseline (twice before the intervention), 3 weeks (immediately after the intervention), 3 weeks follow-up, 3 months follow-up

  3. Acoustic Voice Quality Index (AVQI)

    A lower AVQI indicates a better voice quality. The index ranges from 0 to 10 for normal to severely dysphonic voices. An AVQI of 2.95 is the threshold separating normophonic from dysphonic persons.

    Measured: baseline (twice before the intervention), 3 weeks (immediately after the intervention), 3 weeks follow-up, 3 months follow-up

  4. Consensus Auditory-Perceptual Evaluation of Voice (CAPE-V)

    The CAPE-V will be used to provide an auditory-perceptual evaluation of the voice quality. This visual analogue scale will examine the voice based on the parameters grade, roughness, breathiness, asthenia, strain, instability, pitch and loudness.

    Measured: baseline (twice before the intervention), 3 weeks (immediately after the intervention), 3 weeks follow-up, 3 months follow-up

  5. Voice Handicap Index

    VHI: A lower index indicates less impact of the voice impairment on the quality of life. The VHI ranges from 0 to 120.

    Measured: baseline (twice before the intervention), 3 weeks (immediately after the intervention), 3 weeks follow-up, 3 months follow-up

Secondary outcomes (10)
  1. Maximum phonation time (MPT)

    The MPT is measured using a chronometer and the best trial out of three attempts is selected for further analysis. Participants are instructed to sustain the vowel /a:/ at their habitual pitch and loudness after a maximal inspiration. Verbal encouragement is employed to maximize phonation duration

    Measured: baseline (twice before the intervention), 3 weeks (immediately after the intervention), 3 weeks follow-up, 3 months follow-up

  2. Fundamental frequency (fo)

    To assess fo participants will produce the vowel /a:/ at their habitual pitch and loudness for three seconds, following an automatic series (counting to three).

    Measured: baseline (twice before the intervention), 3 weeks (immediately after the intervention), 3 weeks follow-up, 3 months follow-up

  3. Jitter

    To assess the jitter participants will produce the vowel /a:/ at their habitual pitch and loudness for three seconds, following an automatic series (counting to three).

    Measured: baseline (twice before the intervention), 3 weeks (immediately after the intervention), 3 weeks follow-up, 3 months follow-up

  4. Shimmer

    To assess the shimmer participants will produce the vowel /a:/ at their habitual pitch and loudness for three seconds, following an automatic series (counting to three).

    Measured: baseline (twice before the intervention), 3 weeks (immediately after the intervention), 3 weeks follow-up, 3 months follow-up

  5. Noise to Harmonics Ratio (NHR)

    To assess NHR participants will produce the vowel /a:/ at their habitual pitch and loudness for three seconds, following an automatic series (counting to three).

    Measured: baseline (twice before the intervention), 3 weeks (immediately after the intervention), 3 weeks follow-up, 3 months follow-up

  6. Voice Range Profile (VRP)

    The VRP indicates the vocal capabilities by examining the range of both fundamental frequency and intensity. The participants will produce the vowel /a:/ respectively at their minimum pitch, minimum intensity, maximum pitch, and maximum intensity to determine their VRP (lowest and highest fundamental frequency (Flow, Fhigh) and lowest and highest intensity (Ilow, Ihigh)).

    Measured: baseline (twice before the intervention), 3 weeks (immediately after the intervention), 3 weeks follow-up, 3 months follow-up

  7. Vocal Tract Discomfort Scale (VTDS)

    VTDS: A lower index indicates less discomfort in the vocal tract. The index ranges from 0 to 96.

    Measured: baseline (twice before the intervention), 3 weeks (immediately after the intervention), 3 weeks follow-up, 3 months follow-up

  8. Vocal Fatigue Index (VFI)

    VFI: A lower index indicates less vocal fatigue. The index ranges from 0 to 76.

    Measured: baseline (twice before the intervention), 3 weeks (immediately after the intervention), 3 weeks follow-up, 3 months follow-up

  9. Singing Voice Handicap Index 10 (SVHI-10)

    Only used with singers. The SVHI-10-NL is used assess self-perceived voice handicap among singers with singing voice difficulties. A higher index indicates a greater perceived singing voice handicap and scores of 14 or above are considered deviant. The index ranges from 0 to 40.

    Measured: baseline (twice before the intervention), 3 weeks (immediately after the intervention), 3 weeks follow-up, 3 months follow-up

  10. Evaluation of Ability to Sing Easily (EASE-NL)

    Only used with singers. The EASE-NL is a tool to assess singer's perceptions of the current status of their singing voice. It is more sensitive to detect subtle changes of the singer's voice. A higher index indicates a more deviant score. The index ranges from 0 to 60.

    Measured: baseline (twice before the intervention), 3 weeks (immediately after the intervention), 3 weeks follow-up, 3 months follow-up

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted7 May 2025
  2. Study start8 May 2025 (estimated)
  3. Primary completion31 Dec 2027 (estimated)
  4. Study completion30 Sep 2028 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Participant, Investigator
Enrolment
144 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06960772
Sponsor's protocol ID
ONZ-2025-0017
Status last verified
Apr 2025
First submitted
28 Apr 2025
Last updated
7 May 2025
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Flow Ball Intervention and Straw Phonation Intervention in people with Prevention of Voice Disorders in Professional Voice Users and Treatment of Functional Voice Disorders in Professional Voice Users, run by University Ghent at 1 site in Belgium.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 9 inclusion and 15 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 7 May 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Belgium. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Casey Dewanckele (+32491547192, casey.dewanckele@ugent.be), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Flexible Strobovideolaryngoscopy (time frame: baseline (before the intervention) and 3 weeks (immediately after the intervention)). The study lists 5 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 7 May 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in